Unicycive Therapeutics, Inc. - UNCY
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G/A | RA Capital Management, L.P. | 9.9% | 2,385,279 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Peter Kolchinsky | 9.9% | 2,385,279 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Rajeev Shah | 9.9% | 2,385,279 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | RA Capital Healthcare Fund, L.P. | 9.9% | 2,385,279 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Nantahala Capital Management, LLC | 9.99% | 2,281,040 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Wilmot B. Harkey | 9.99% | 2,281,040 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Daniel Mack | 9.99% | 2,281,040 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Octagon Capital Advisors LP | 4.7% | 1,000,000 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Octagon Investments Master Fund LP | 3.0% | 650,000 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Octagon Biotech Opportunities Fund I LP | 1.7% | 350,000 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | Ting Jia | 4.7% | 1,000,000 | View |
| Jan 23, 2026 | SCHEDULE 13G | — | — | — | View |
| Nov 14, 2025 | SCHEDULE 13G/A | RA Capital Management, L.P. | 9.9% | 1,960,230 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Peter Kolchinsky | 9.9% | 1,960,230 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Rajeev Shah | 9.9% | 1,960,230 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | RA Capital Healthcare Fund, L.P. | 9.9% | 1,960,230 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Vivo Opportunity Fund Holdings, L.P. | 9.99% | 6,096,175 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Vivo Opportunity, LLC | 9.99% | 6,096,175 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Octagon Capital Advisors LP | 5.7% | 1,000,000 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Octagon Investments Master Fund LP | 3.7% | 650,000 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Octagon Private Opportunities Fund II LP | 2.0% | 350,000 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Ting Jia | 5.7% | 1,000,000 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Great Point Partners, LLC | 4.51% | 796,558 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Dr. Jeffrey R. Jay, M.D. | 4.51% | 796,558 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Ms. Lillian Nordahl | 4.51% | 796,558 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Nantahala Capital Management, LLC | 9.99% | 1,855,991 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Wilmot B. Harkey | 9.99% | 1,855,991 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Daniel Mack | 9.99% | 1,855,991 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.